IFNG and glioma: This phenomenon was predominantly dependent on antigen presentation, as IFN-γ treated Chek2 KO glioma cells failed to activate CD8+ T cells from WT C57BL/6 mice (“WT CD8 T” panel, Fig. 4e) (Supplementary Fig. 8).